Pretesting cervical tumors could inform treatment

Doctors at the School of Medicine have shown that testing cervical tumors before treatment for vulnerability to chemotherapy predicts whether patients will do well or poorly with standard treatment. The study supports the future possibility of personalized medicine for cervical cancer, a tumor normally addressed with a one-size-fits-all approach. Pictured is a cervical tumor visible on a PET/CT scan.

Campus Author: The Japanese Supreme Court and Judicial Review

.ExternalClass p.MsoNormal, .ExternalClass li.MsoNormal, .ExternalClass div.MsoNormal {margin-top:0in;margin-right:0in;margin-bottom:10.0pt;margin-left:0in;line-height:115%;font-size:11.0pt;font-family:Calibri;} .ExternalClass .MsoChpDefault {font-size:11.0pt;font-family:Calibri;} .ExternalClass .MsoPapDefault {margin-bottom:10.0pt;line-height:115%;} @page WordSection1 {size:8.5in 11.0in;margin:1.0in 1.25in 1.0in 1.25in;} .ExternalClass div.WordSection1 {page:WordSection1;} David S. Law, JD, PhD, professor of law and professor of political science, has published a groundbreaking book on the Japanese judiciary and constitutional adjudication in Japan, titled The Japanese Supreme Court and Judicial Review (Gendaijinbunsha, 2013). Read more at http://law.wustl.edu/news/pages.aspx?id=9740.

Deadly infections cut in sickest hospital patients

A major study in hospital ICUs shows that bathing patients daily with an antimicrobial soap and applying antibiotic ointment in the nose reduced by 44 percent the bloodstream infections caused by dangerous pathogens, including the drug-resistant bacteria MRSA (pictured).